메뉴 건너뛰기




Volumn 878, Issue 5-6, 2010, Pages 525-537

Liquid chromatography and tandem mass spectrometry for the quantitative determination of ixabepilone (BMS-247550, Ixempra™) in human plasma: Method validation, overcoming curve splitting issues and eliminating chromatographic interferences from degradants

Author keywords

Adsorption; BMS 247550; Calibration issues; Degradants; Ixabepilone; Ixempra ; LC MS MS; Protein precipitation

Indexed keywords

ACCURACY AND PRECISION; AMMONIUM ACETATE; BIOLOGICAL MATRIXES; CLINICAL STUDY; DEGRADANTS; HUMAN PLASMAS; INTERNAL STANDARDS; ION PAIRS; IONIZATION MODES; LC-MS/MS; METHOD VALIDATIONS; MOBILE PHASE; MULTIPLE REACTION MONITORING; ORAL ADMINISTRATION; PLASMA SAMPLES; POTENTIAL INTERFERENCES; PROTEIN PRECIPITATION; QUADRATIC REGRESSION; QUANTITATIVE ANALYSIS; QUANTITATIVE DETERMINATIONS; SAMPLE ANALYSIS; SENSITIVE METHOD; TANDEM MASS SPECTROMETRY; TURBOIONSPRAY;

EID: 75349097967     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2009.12.014     Document Type: Article
Times cited : (18)

References (14)
  • 12
    • 0003484310 scopus 로고    scopus 로고
    • Food and Drug Administration, US Department of Health and Human Services
    • Food and Drug Administration, US Department of Health and Human Services, Guidance for Industry: Bioanalytical Method Validation, 2001.
    • (2001) Guidance for Industry: Bioanalytical Method Validation


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.